MakowskiMBhagatRChevalierS, et al. Historical benchmarks for quality tolerance limits parameters in clinical trials. Ther Innov Regul Sci2021; 55(6): 1265–1273.
4.
de VironSTrottaLSchumacherH, et al. Detection of fraud in a clinical trial using unsupervised statistical monitoring. Ther Innov Regul Sci2022; 56(1): 130–136.
5.
MénardTBowlingRMehtaP, et al. Leveraging analytics to assure quality during the Covid-19 pandemic – The COVACTA clinical study example. Contemp Clin Trials Commun2020; 20: 100662.
6.
MénardTYoungKSiegelL, et al. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: the IMPALA industry group. CPT Pharmacometrics Syst Pharmacol2021; 10(8): 799–803.
7.
HavenhandSKoneswarakanthaBRoloD, et al. Building data analytics skills for clinical drug development quality professionals – the Data Analytics University training program. Research Square Preprint, 2021. DOI: 10.21203/rs.3.rs-199575/v2.
